Ncam binding compounds
CA 2459937 A1 · Owner: Berezin, Vladimir · Inventors: Holm, Arne Valdemar; Berezin, Vladimir; Poulsen, Flemming Martin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns an NCAM (neural cell adhesion molecule) binding compound capable of stimulating NCAM signalling and/or interfering with cell adhesion. The compound is a peptide having a sequence of the formula L1-A-L2-B- L3-C-L4, wherein A,B or Cis any amino acid residue with the proviso that at , least B or C is an acidic amino acid residue and at least A, B, or C is a , hydrophobic amino acid residue or Y or A, B or C is any amino acid residue with the proviso that at least B or C is an basic amino acid residue and at , least A, B, or C is a hydrophobic amino acid residue or Y and L1, L2, L3 and , L4 is individually selected from a chemical bond or an amino acid sequence …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.